Minimally Invasive Surgery Market - Global Forecast to 2030
商品番号 : SMB-54548
| 出版社 | MarketsandMarkets |
| 出版年月 | 2025年9月 |
| ページ数 | 390 |
| 図表数 | 519 |
| 価格タイプ | シングルユーザライセンス |
| 価格 | USD 4,950 |
| 種別 | 英文調査報告書 |
本レポートは、低侵襲手術市場をコンポーネント、技術、エンドユーザー、地域の観点から分析しています。また、市場成長に影響を与える推進要因、制約要因、機会、課題といった要因を分析し、市場リーダー企業の競争環境を概説しています。さらに、マイクロ市場とそれぞれの成長傾向を概観し、5つの主要地域とそれぞれの国における市場セグメントの収益予測も提供しています。
本レポートは、既存企業と中小規模企業の両方にとって、市場の動向を把握し、ひいては市場シェアの拡大を支援するのに役立ちます。本レポートを購入した企業は、以下に示す戦略のいずれか、または組み合わせて活用することで、市場でのプレゼンスを強化できます。
世界の低侵襲手術市場は、2025年の9,445万米ドルから2030年には1億9,930万米ドルに達し、予測期間中に16.1%の年平均成長率（CAGR）で成長すると予測されています。
低侵襲手術市場の成長は、頻繁な外科的介入を必要とすることが多い胃腸疾患、がん、心血管疾患などの慢性疾患の罹患率増加に牽引されています。患者と医療提供者は、回復期間の短縮、合併症の減少、入院期間の短縮など、開腹手術に比べてMISの利点があるため、ますますMISを選択するようになっています。さらに、病院数の増加、医療インフラの改善、入院患者数の増加が、高度な外科的選択肢に対する需要を押し上げています。これらの要因と継続的な技術革新により、様々な専門分野でMIS手術の世界的な導入が加速しています。
The global minimally invasive surgery market is projected to reach USD 199.30 million by 2030 from USD 94.45 million in 2025, at a CAGR of 16.1% during the forecast period. The growth of the minimally invasive surgery market is fueled by the increasing prevalence of chronic diseases such as gastrointestinal disorders, cancer, and cardiovascular conditions, which often require frequent surgical intervention. Patients and providers are more and more favoring MIS because of its advantages over open surgery, including shorter recovery times, fewer complications, and reduced hospital stays. Furthermore, the expanding number of hospitals, better healthcare infrastructure, and rising hospital admissions are boosting the demand for advanced surgical options. These factors, along with continuous technological innovation, are speeding up the global adoption of MIS procedures across various specialties.
The handheld instruments segment of the minimally invasive surgery market, by type of surgical device, had the highest market share in 2024.
By product, the global minimally invasive surgery market is segmented into surgical devices, imaging & visualization systems, electrosurgical devices, endoscopy devices, and medical robotics. Among these, in 2024, the surgical devices segment held the largest market share. This segment is further broken down into handheld instruments, guiding devices, inflation systems, and laparoscopy devices. In 2024, the handheld instruments segment had the highest share, due to their wide application, affordability, and ease of use across various surgical fields. These mechanical tools—such as graspers, retractors, dilators, forceps, and suturing devices—are vital in laparoscopic, cardiothoracic, urological, neurological, and cardiovascular surgeries. Their versatility and compatibility with standard MIS systems make them essential in both advanced and resource-limited healthcare environments. Surgeons favor these instruments for their ergonomic design, tactile feedback, and precise control. Moreover, their reusability and lower maintenance costs improve hospital procurement efficiency. The global rise in MIS procedures, especially in general and specialized surgeries, continues to boost demand, maintaining this segment’s market leadership.
The cardiothoracic surgery segment of the minimally invasive surgery market had the second-highest market share in 2024, based on application.
Based on application, the minimally invasive surgery market is segmented into cardiothoracic surgery, vascular surgery, neurological surgery, ENT & respiratory surgery, cosmetic surgery, gastrointestinal & abdominal surgery, gynecological surgery, urological surgery, orthopedic surgery, oncology surgery, dental surgery, and other applications. In 2024, the cardiothoracic surgery segment held the second-highest market share, driven by the global high burden of cardiovascular diseases. According to the CDC, heart disease remains the leading cause of death in the U.S., with 919,032 deaths in 2023, equal to one in every three deaths and one death every 34 seconds. This alarming rate of prevalence increases the demand for effective, less invasive surgical options. Minimally invasive cardiothoracic procedures provide notable advantages, such as less trauma, shorter hospital stays, and quicker recovery, making them more favored by both patients and healthcare providers. Innovations like robotic-assisted systems and minimally invasive valve replacements further boost adoption, strengthening this segment’s prominent role in the overall MIS market.
In 2024, North America accounted for the largest share of the minimally invasive surgery market.
The global minimally invasive surgery market is segmented into five major regions, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. Among these in 2024, the North American region held the largest share in the minimally invasive surgery market, driven by the high prevalence of chronic diseases, increasing demand for cosmetic procedures, and the presence of leading medical device manufacturers. According to the CDC, as of 2024, 129 million Americans have at least one chronic disease, with 6 in 10 Americans having at least one, and 4 in 10 having two or more chronic diseases. This growing disease burden drives demand for less invasive, more effective surgical options. Additionally, cosmetic minimally invasive procedures are experiencing strong growth, with over 9.8 million neuromodulator injections (up 4%) and 3.7 million skin resurfacing procedures (up 6%) performed in 2024, indicating rising patient preference. The region also benefits from advanced healthcare infrastructure, favorable reimbursement policies, and widespread adoption of innovative technologies. Furthermore, the presence of major industry players like Johnson & Johnson, Stryker, Boston Scientific, Abbott, and Intuitive Surgical ensures ongoing product innovation and availability, solidifying North America’s leadership in the global MIS market.
A breakdown of the primary participants referred to for this report is provided below:
- By Company Type: Tier 1- 40%, Tier 2- 30%, and Tier 3- 30%
- By Designation: C-level- 50%, Director level- 30%, and Others- 20%
- By Region: North America- 30%, Europe- 25%, Asia Pacific- 20%, Latin America- 15%, and Middle East & Africa- 10%.
Note 1: Companies are classified into tiers based on their total revenue. As of 2024, Tier 1 = >USD 10.0 billion, Tier 2 = USD 1.0 billion to USD 10.0 billion, and Tier 3 = <USD 1.0 billion.
Note 2: C-level primaries include CEOs, CFOs, COOs, and VPs.
Note 3: Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.
The players operating in the minimally invasive surgery market include Medtronic (Ireland), Johnson & Johnson (US), Stryker (US), Boston Scientific Corporation (US), Siemens Healthineers AG (Germany), Abbott (US), GE HealthCare (US), Koninklijke Philips N.V. (Netherland), Intuitive Surgical Operations, Inc. (US), FUJIFILM Corporation (Japan), B Braun SE (Germany), Globus Medical, Inc. (US), Integra LifeSciences Corporation (US), KARL STORZ SE & Co. KG (Germany), Nipro (Japan), Smith+Nephew (UK), Getinge AB (Sweden), CONMED Corporation (US), Teleflex Incorporated (US), Olympus Corporation (Japan), CooperSurgical, Inc. (US), Applied Medical Resources Corporation (US), OTU Medical Inc. (US), and ATMOS MedizinTechnik GmbH & Co. KG (Germany).
Research Coverage
This report examines the minimally invasive surgery market based on component, technology, end user, and region. It also analyzes factors such as drivers, restraints, opportunities, and challenges that influence market growth, and outlines the competitive landscape of market leaders. Additionally, the report reviews micro markets and their individual growth trends, and forecasts the revenue of market segments across five major regions and their respective countries.
Reasons to Buy the Report
The report will help both established and smaller firms gauge the market pulse, which can, in turn, assist them in gaining a larger market share. Firms purchasing the report can use one or a combination of the strategies mentioned below to strengthen their market presence.
This report provides insights on the following pointers:
- Analysis of key drivers (increasing number of hospitals and surgeries, Increasing adoption of MIS over open surgeries, advantages of robot-assisted surgery & training in rehabilitation therapy), restraints (high cost of robotic systems), opportunities (emerging markets, increasing adoption of advanced robotics in ambulatory surgical centers), challenges (changing regulatory landscape in medical devices).
- Market Penetration: Complete knowledge of the spectrum of products presented by the major companies in the minimally invasive surgery market
- Product Development/Innovation: Comprehensive understanding of the forthcoming trends, research and development initiatives, and product launches within the minimally invasive surgery market
- Market Development: Complete knowledge about profitable developing regions
- Market Diversification: Exhaustive knowledge of new goods, expanding geographies, and current changes in the minimally invasive surgery industry helps to diversify the market
- Competitive Assessment: In-depth assessment of market shares, growth strategies, and product offerings of leading players like Medtronic (Ireland), Johnson & Johnson (US), Stryker (US), Boston Scientific Corporation (US), Siemens Healthineers AG (Germany), Abbott (US), GE HealthCare (US), Koninklijke Philips N.V. (Netherland), Intuitive Surgical Operations, Inc. (US), FUJIFILM Corporation (Japan), and among others.
Table of Contents
1 INTRODUCTION 34
1.1 STUDY OBJECTIVES 34
1.2 MARKET DEFINITION 34
1.3 STUDY SCOPE 35
1.3.1 MARKET SEGMENTATION & REGIONAL SCOPE 35
1.3.2 INCLUSIONS & EXCLUSIONS 36
1.3.3 YEARS CONSIDERED 37
1.3.4 CURRENCY CONSIDERED 38
1.4 STAKEHOLDERS 38
1.5 SUMMARY OF CHANGES 39
2 RESEARCH METHODOLOGY 40
2.1 RESEARCH DATA 40
2.1.1 SECONDARY RESEARCH 40
2.1.1.1 Key objectives of secondary research 41
2.1.1.2 Key sources of secondary data 41
2.1.1.3 Key data from secondary sources 42
2.1.2 PRIMARY RESEARCH 42
2.1.2.1 Key primary sources 43
2.1.2.2 Key objectives of primary research 43
2.1.2.3 Key data from primary sources 44
2.1.2.4 Key industry insights 45
2.2 MARKET SIZE ESTIMATION 46
2.2.1 SUPPLY-SIDE ANALYSIS (REVENUE SHARE ANALYSIS) 46
2.2.2 TOP-DOWN APPROACH 47
2.2.3 COMPANY PRESENTATIONS & PRIMARY INTERVIEWS 47
2.2.4 DEMAND-SIDE MODELLING 47
2.3 DATA TRIANGULATION 50
2.4 MARKET RANKING ANALYSIS 50
2.5 STUDY ASSUMPTIONS 51
2.6 RESEARCH LIMITATIONS 51
2.6.1 METHODOLOGY-RELATED LIMITATIONS 51
2.6.2 SCOPE-RELATED LIMITATIONS 51
2.7 RISK ANALYSIS 52
3 EXECUTIVE SUMMARY 53
4 PREMIUM INSIGHTS 57
4.1 MINIMALLY INVASIVE SURGERY MARKET OVERVIEW 57
4.2 NORTH AMERICA: MINIMALLY INVASIVE SURGERY MARKET,
BY END USER AND COUNTRY 58
4.3 MINIMALLY INVASIVE SURGERY MARKET: GEOGRAPHIC SNAPSHOT 59
4.4 MINIMALLY INVASIVE SURGERY MARKET: REGIONAL MIX 59
4.5 MINIMALLY INVASIVE SURGERY MARKET: EMERGING VS. DEVELOPED MARKETS 60
5 MARKET OVERVIEW 61
5.1 INTRODUCTION 61
5.2 MARKET DYNAMICS 61
5.2.1 DRIVERS 62
5.2.1.1 Rising geriatric population and increasing number of surgeries 62
5.2.1.2 Growing adoption of minimally invasive surgeries over traditional open surgical procedures 62
5.2.1.3 Advantages of robot-assisted surgery and training in rehabilitation therapy 63
5.2.2 RESTRAINTS 63
5.2.2.1 High cost of robotic systems 63
5.2.3 OPPORTUNITIES 63
5.2.3.1 High growth opportunities in emerging markets 63
5.2.3.2 Increasing adoption of advanced robotics in ambulatory surgery centers 64
5.2.4 CHALLENGES 64
5.2.4.1 Changing regulatory landscape in medical device industry 64
5.3 TECHNOLOGY ANALYSIS 64
5.3.1 KEY TECHNOLOGIES 64
5.3.1.1 Laparoscopy 64
5.3.1.2 Electrosurgery 65
5.3.2 COMPLEMENTARY TECHNOLOGIES 65
5.3.2.1 Robotic surgery 65
5.3.2.2 Medical and surgical imaging 65
5.3.3 ADJACENT TECHNOLOGIES 65
5.3.3.1 Artificial intelligence and machine learning 65
5.4 INDUSTRY TRENDS 66
5.4.1 INTEGRATION OF ARTIFICAL INTELLIGENCE AND MACHINE LEARNING 66
5.4.2 TECHNOLOGICAL ADVANCEMENTS IN IMAGING 66
5.5 VALUE CHAIN ANALYSIS 66
5.6 ECOSYSTEM ANALYSIS 67
5.7 SUPPLY CHAIN ANALYSIS 68
5.8 TRADE ANALYSIS 69
5.8.1 IMPORT DATA FOR HS CODE 9018, 2019–2024 69
5.8.2 EXPORT SCENARIO FOR HS CODE 9018, 2019–2024 70
5.9 PORTER’S FIVE FORCES ANALYSIS 71
5.9.1 THREAT OF NEW ENTRANTS 72
5.9.2 THREAT OF SUBSTITUTES 72
5.9.3 BARGAINING POWER OF BUYERS 72
5.9.4 BARGAINING POWER OF SUPPLIERS 72
5.9.5 INTENSITY OF COMPETITIVE RIVALRY 73
5.10 KEY STAKEHOLDERS & BUYING CRITERIA 73
5.10.1 KEY STAKEHOLDERS IN BUYING PROCESS 73
5.10.2 KEY BUYING CRITERIA 74
5.11 REGULATORY ANALYSIS 75
5.11.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 75
5.11.2 REGULATORY FRAMEWORK 77
5.11.2.1 North America 77
5.11.2.1.1 US 77
5.11.2.1.2 Canada 78
5.11.2.2 Europe 79
5.11.2.3 Asia Pacific 79
5.11.2.3.1 Japan 79
5.11.2.3.2 China 80
5.11.2.3.3 India 81
5.11.2.4 Latin America 81
5.11.2.5 Middle East & Africa 81
5.12 PATENT ANALYSIS 82
5.12.1 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS 83
5.13 PRICING ANALYSIS 83
5.13.1 AVERAGE SELLING PRICE TREND OF MINIMALLY INVASIVE SURGICAL PRODUCTS, BY KEY PLAYER 83
5.13.2 AVERAGE SELLING PRICE TREND OF MINIMALLY INVASIVE SURGICAL PRODUCTS, BY REGION, 2022–2024 85
5.14 KEY CONFERENCES & EVENTS, 2025–2026 86
5.15 ADJACENT MARKET ANALYSIS 86
5.15.1 ENDOSCOPY EQUIPMENT MARKET 86
5.16 UNMET NEEDS/END-USER EXPECTATIONS 87
5.17 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS 88
5.18 INVESTMENT & FUNDING SCENARIO 88
5.19 IMPACT OF AI/GEN AI ON MINIMALLY INVASIVE SURGERY MARKET 89
5.20 IMPACT OF 2025 US TARIFF ON MINIMALLY INVASIVE SURRGERY MARKET 90
5.20.1 INTRODUCTION 90
5.20.2 KEY TARIFF RATES 91
5.20.3 PRICE IMPACT ANALYSIS 92
5.20.4 KEY IMPACT ON COUNTRY/REGION 92
5.20.4.1 North America 92
5.20.4.1.1 US 92
5.20.4.2 Europe 93
5.20.4.3 Asia Pacific 93
5.20.5 IMPACT ON END-USE INDUSTRIES 93
6 MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT 94
6.1 INTRODUCTION 95
6.2 SURGICAL DEVICES 96
6.2.1 HANDHELD INSTRUMENTS 98
6.2.1.1 Tubular retractors 99
6.2.1.1.1 Minimized tissue trauma and better outcomes to support adoption 99
6.2.1.2 Dilators 100
6.2.1.2.1 Increased focus on safety and efficient surgical site access to boost segment growth 100
6.2.1.3 Suturing instruments 101
6.2.1.3.1 Rising demand and procedural volume for minimally invasive surgeries to drive market 101
6.2.1.4 Probes 102
6.2.1.4.1 Advancements in instrumentation to fuel adoption in diagnostic purposes 102
6.2.1.5 Laser fiber devices 103
6.2.1.5.1 Laser fiber devices to focus on precise and controlled procedures with minimal tissue trauma 103
6.2.2 LAPAROSCOPY DEVICES 104
6.2.2.1 Laparoscopes 106
6.2.2.1.1 Lower surgical infection risk to drive demand 106
6.2.2.2 Trocars & cannulas 107
6.2.2.2.1 Need to ensure accurate placement of medications during surgeries to support segment growth 107
6.2.2.3 Graspers & dissectors 108
6.2.2.3.1 Increased safety and better precision to fuel market growth 108
6.2.3 INFLATION SYSTEMS 109
6.2.3.1 Balloon catheters 110
6.2.3.1.1 Increasing prevalence of cardiovascular diseases to boost market growth 110
6.2.3.2 Balloon inflation systems 111
6.2.3.2.1 Growing adoption of minimally invasive coronary and peripheral procedures to accelerate market growth 111
6.2.4 GUIDING DEVICES 112
6.2.4.1 Guiding catheters 113
6.2.4.1.1 Rising demand for precise navigation and device placement in complex minimally invasive surgeries to drive demand 113
6.2.4.2 Guidewires 114
6.2.4.2.1 Rising PCTA and PTA procedural volumes to ensure demand growth 114
6.3 IMAGING & VISUALIZATION SYSTEMS 115
6.3.1 ULTRASOUND SYSTEMS 116
6.3.1.1 Rising chronic disease burden to drive demand for reliable, non-invasive ultrasound imaging 116
6.3.1.2 CT scanners 118
6.3.1.2.1 Rising demand for high-resolution imaging in complex minimally invasive surgeries to support market growth 118
6.3.2 MRI SYSTEMS 119
6.3.2.1 Rising cancer prevalence to increase reliance on MRI for early detection and image-guided surgeries 119
6.3.3 X-RAY SYSTEMS 121
6.3.3.1 Rapid, low-cost digital imaging and high patient throughput to favor market growth 121
6.3.4 OTHER IMAGING & VISUALIZATION SYSTEMS 122
6.4 ELECTROSURGAL DEVICES 123
6.4.1 ELECTROCAUTERY DEVICES 124
6.4.1.1 High demand for precise cutting and coagulation to boost electrocautery device use in minimally invasive procedures 124
6.4.2 ELECTROSURGICAL GENERATORS & ACCESSORIES 125
6.4.2.1 Growing use of disposables and reusable instruments to propel segment growth 125
6.5 ENDOSCOPY DEVICES 126
6.5.1 RIGID ENDOSCOPES 128
6.5.1.1 Rising joint and urologic disorders to drive demand in high-volume minimally invasive surgeries 128
6.5.2 FLEXIBLE ENDOSCOPES 129
6.5.2.1 Increased preventive screening and early cancer detection to elevate flexible endoscope adoption 129
6.6 MEDICAL ROBOTICS 130
6.6.1 ROBOTIC SYSTEMS 131
6.6.1.1 Superior precision, enhanced control, and ability to perform complex procedures with greater dexterity to drive market 131
6.6.2 ROBOTIC INSTRUMENTS 132
6.6.2.1 Growing volume of robotic surgical procedures to augment market growth 132
6.6.3 ROBOTIC SOFTWARE & SERVICES 133
6.6.3.1 Rising robotic installations to increase demand for bundled training, maintenance, and technical support services 133
7 MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION 135
7.1 INTRODUCTION 136
7.2 GASTROINTESTINAL & ABDOMINAL SURGERY 137
7.2.1 RISING GLOBAL BURDEN OF GASTROINTESTINAL CANCERS AND DIGESTIVE DISORDERS TO DRIVE MARKET 137
7.3 CARDIOTHORACIC SURGERY 138
7.3.1 INCREASING CARDIOVASCULAR AND THORACIC CONDITIONS TO INCREASE PRECISION-BASED MINIMALLY INVASIVE PROCEDURES 138
7.4 ORTHOPEDIC SURGERY 139
7.4.1 RISING BURDEN OF MUSCULOSKELETAL DISORDERS AND GROWING GERIATRIC POPULATION TO AID MARKET GROWTH 139
7.5 VASCULAR SURGERY 140
7.5.1 MINIMALLY INVASIVE VASCULAR SURGERY PRODUCTS TO REPLACE CONVENTIONAL SUTURE-BASED METHODS 140
7.6 GYNECOLOGICAL SURGERY 141
7.6.1 HIGH INCIDENCE OF GYNECOLOGICAL DISORDERS TO FUEL SEGMENT GROWTH 141
7.7 ONCOLOGICAL SURGERY 142
7.7.1 HIGH CANCER INCIDENCE AND ADOPTION OF ADVANCED PRECISION SURGICAL TECHNOLOGIES TO BOOST MARKET GROWTH 142
7.8 NEUROLOGICAL SURGERY 143
7.8.1 INCREASING GERIATRIC POPULATION AND RISING OCCURRENCE OF NEURODEGENERATIVE DISORDERS TO PROPEL MARKET GROWTH 143
7.9 UROLOGICAL SURGERY 144
7.9.1 INCREASING PREVALENCE OF UROLOGICAL CANCERS TO AUGMENT MARKET GROWTH 144
7.10 ENT & RESPIRATORY SURGERY 145
7.10.1 GROWING GLOBAL BURDEN OF COPD AND HEAD & NECK CANCERS TO DRIVE MARKET 145
7.11 COSMETIC SURGERY 146
7.11.1 HIGH DEMAND FOR AESTHETIC ENHANCEMENT WITH MINIMAL DOWNTIME TO PROPEL MARKET GROWTH 146
7.12 DENTAL SURGERY 147
7.12.1 RISING PATIENT DEMAND FOR LESS PAINFUL AND TISSUE-PRESERVING TREATMENTS TO FAVOR MARKET GROWTH 147
7.13 OTHER SURGERIES 148
8 MINIMALLY INVASIVE SURGERY MARKET, BY END USER 149
8.1 INTRODUCTION 150
8.2 HOSPITALS 150
8.2.1 RISING CHRONIC DISEASE BURDEN TO DRIVE PATIENT PREFERENCE FOR ADVANCED MINIMALLY INVASIVE SURGERIES IN HOSPITALS 150
8.3 AMBULATORY SURGERY CENTERS 151
8.3.1 GROWING PATIENT PREFERENCE FOR QUICKER DISCHARGE AND LOWER COSTS TO BOOST MARKET GROWTH 151
8.4 CLINICS 153
8.4.1 PREFERENCE FOR OUTPATIENT AND COST-EFFECTIVE MINIMALLY INVASIVE SURGICAL PROCEDURES TO AID MARKET GROWTH 153
8.5 EMERGENCY & TRAUMA CENTERS 154
8.5.1 INCREASING DEMAND FOR SAME-DAY SURGERIES TO AUGMENT MARKET GROWTH 154
8.6 OTHER END USERS 155
9 MINIMALLY INVASIVE SURGERY MARKET, BY REGION 156
9.1 INTRODUCTION 157
9.2 NORTH AMERICA 159
9.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 159
9.2.2 US 166
9.2.2.1 US to dominate North American minimally invasive surgery market during forecast period 166
9.2.3 CANADA 171
9.2.3.1 High geriatric population with chronic diseases to propel market growth 171
9.3 EUROPE 176
9.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 176
9.3.2 GERMANY 184
9.3.2.1 Increased cancer incidence and strong healthcare infrastructure to fuel market growth 184
9.3.3 UK 189
9.3.3.1 Increasing geriatric population and rising need for oncological surgeries to stimulate market growth 189
9.3.4 FRANCE 194
9.3.4.1 High burden of non-communicable diseases to accelerate demand for minimally invasive procedures 194
9.3.5 ITALY 199
9.3.5.1 Increasing geriatric population to support adoption of minimally invasive procedures in degenerative conditions 199
9.3.6 SPAIN 204
9.3.6.1 Robust public healthcare and focus on reduced post-operative complications to augment market growth 204
9.3.7 REST OF EUROPE 209
9.4 ASIA PACIFIC 214
9.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 214
9.4.2 CHINA 220
9.4.2.1 Growing need for less invasive and high-precision surgical interventions to drive market 220
9.4.3 INDIA 225
9.4.3.1 Need for cost-effective and efficient surgical options in resource-constrained healthcare system to drive adoption 225
9.4.4 JAPAN 230
9.4.4.1 Advanced medical technology adoption and strong focus on patient-centric care to accelerate market growth 230
9.4.5 SOUTH KOREA 235
9.4.5.1 High demand for plastic surgeries and adoption of advanced robotics to aid market growth 235
9.4.6 AUSTRALIA 240
9.4.6.1 Increasing chronic disease burden and booming cosmetic surgery rates to fuel market expansion 240
9.4.7 REST OF ASIA PACIFIC 245
9.5 LATIN AMERICA 250
9.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 250
9.5.2 BRAZIL 256
9.5.2.1 Substantial public health investment and advanced dual public-private healthcare system to favor market growth 256
9.5.3 MEXICO 261
9.5.3.1 Rising obesity across age groups to fuel demand for minimally invasive surgical procedures in Mexican healthcare system 261
9.5.4 REST OF LATIN AMERICA 266
9.6 MIDDLE EAST & AFRICA 271
9.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 271
9.6.2 GCC COUNTRIES 277
9.6.2.1 Increased government healthcare investments and adoption of advanced medical technologies to spur market growth 277
9.6.3 REST OF MIDDLE EAST & AFRICA 283
10 COMPETITIVE LANDSCAPE 288
10.1 INTRODUCTION 288
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 288
10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN MINIMALLY INVASIVE SURGERY MARKET 288
10.3 REVENUE ANALYSIS, 2020–2024 289
10.4 MARKET SHARE ANALYSIS, 2024 290
10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 293
10.5.1 STARS 293
10.5.2 EMERGING LEADERS 293
10.5.3 PERVASIVE PLAYERS 293
10.5.4 PARTICIPANTS 293
10.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 295
10.5.5.1 Company footprint 295
10.5.5.2 Region footprint 296
10.5.5.3 Product footprint 297
10.5.5.4 Application footprint 298
10.5.5.5 End-user footprint 299
10.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 300
10.6.1 PROGRESSIVE COMPANIES 300
10.6.2 RESPONSIVE COMPANIES 300
10.6.3 DYNAMIC COMPANIES 300
10.6.4 STARTING BLOCKS 301
10.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 302
10.6.5.1 Detailed list of key startups/SMEs 302
10.6.5.2 Competitive benchmarking of key startups/SMEs 302
10.7 COMPANY VALUATION & FINANCIAL METRICS 303
10.7.1 FINANCIAL METRICS 303
10.7.2 COMPANY VALUATION 303
10.8 BRAND/PRODUCT COMPARISON 304
10.9 COMPETITIVE SCENARIO 305
10.9.1 PRODUCT LAUNCHES AND APPROVALS 305
10.9.2 DEALS 306
11 COMPANY PROFILES 307
11.1 KEY PLAYERS 307
11.1.1 MEDTRONIC 307
11.1.1.1 Business overview 307
11.1.1.2 Products offered 308
11.1.1.3 Recent developments 313
11.1.1.3.1 Product approvals 313
11.1.1.3.2 Expansions 313
11.1.1.4 MnM view 313
11.1.1.4.1 Right to win 313
11.1.1.4.2 Strategic choices 313
11.1.1.4.3 Weaknesses & competitive threats 314
11.1.2 JOHNSON & JOHNSON 315
11.1.2.1 Business overview 315
11.1.2.2 Products offered 316
11.1.2.3 Recent developments 318
11.1.2.3.1 Product approvals 318
11.1.2.3.2 Deals 318
11.1.2.4 MnM view 319
11.1.2.4.1 Right to win 319
11.1.2.4.2 Strategic choices 319
11.1.2.4.3 Weaknesses & competitive threats 319
11.1.3 STRYKER 320
11.1.3.1 Business overview 320
11.1.3.2 Products offered 321
11.1.3.3 Recent developments 323
11.1.3.3.1 Product launches and approvals 323
11.1.3.3.2 Deals 324
11.1.3.4 MnM view 324
11.1.3.4.1 Right to win 324
11.1.3.4.2 Strategic choices 324
11.1.3.4.3 Weaknesses & competitive threats 324
11.1.4 BOSTON SCIENTIFIC CORPORATION 325
11.1.4.1 Business overview 325
11.1.4.2 Products offered 326
11.1.4.3 Recent developments 327
11.1.4.3.1 Deals 327
11.1.4.4 MnM view 328
11.1.4.4.1 Right to win 328
11.1.4.4.2 Strategic choices 329
11.1.4.4.3 Weaknesses & competitive threats 329
11.1.5 ABBOTT 330
11.1.5.1 Business overview 330
11.1.5.2 Products offered 331
11.1.5.3 Recent developments 332
11.1.5.3.1 Deals 332
11.1.5.4 MnM view 332
11.1.5.4.1 Right to win 332
11.1.5.4.2 Strategic choices 332
11.1.5.4.3 Weaknesses & competitive threats 332
11.1.6 ZIMMER BIOMET 333
11.1.6.1 Business overview 333
11.1.6.2 Products offered 334
11.1.6.3 Recent developments 335
11.1.6.3.1 Product approvals 335
11.1.6.3.2 Deals 335
11.1.7 B. BRAUN SE 336
11.1.7.1 Business overview 336
11.1.7.2 Products offered 337
11.1.8 GLOBUS MEDICAL 339
11.1.8.1 Business overview 339
11.1.8.2 Products offered 340
11.1.8.3 Recent developments 341
11.1.8.3.1 Deals 341
11.1.9 INTEGRA LIFESCIENCES CORPORATION 342
11.1.9.1 Business overview 342
11.1.9.2 Products offered 343
11.1.10 SIEMENS HEALTHINEERS AG 344
11.1.10.1 Business overview 344
11.1.10.2 Products offered 345
11.1.10.3 Recent developments 347
11.1.10.3.1 Product launches 347
11.1.10.3.2 Expansions 348
11.1.11 FUJIFILM CORPORATION 349
11.1.11.1 Business overview 349
11.1.11.2 Products offered 350
11.1.11.3 Recent developments 352
11.1.11.3.1 Product launches and approvals 352
11.1.11.3.2 Deals 352
11.1.12 KONINKLIJKE PHILIPS N.V. 353
11.1.12.1 Business overview 353
11.1.12.2 Products offered 354
11.1.12.3 Recent developments 356
11.1.12.3.1 Product launches and approvals 356
11.1.12.3.2 Deals 357
11.1.13 INTUITIVE SURGICAL OPERATIONS, INC. 358
11.1.13.1 Business overview 358
11.1.13.2 Products offered 359
11.1.13.3 Recent developments 360
11.1.13.3.1 Product approvals 360
11.1.14 KARL STORZ SE & CO. KG 361
11.1.14.1 Business overview 361
11.1.14.2 Products offered 361
11.1.14.3 Recent developments 363
11.1.14.3.1 Deals 363
11.1.14.3.2 Expansions 363
11.1.15 GE HEALTHCARE 364
11.1.15.1 Business overview 364
11.1.15.2 Products offered 365
11.1.15.3 Recent developments 367
11.1.15.3.1 Product launches 367
11.1.15.3.2 Deals 367
11.2 OTHER PLAYERS 368
11.2.1 NIPRO 368
11.2.2 SMITH+NEPHEW 369
11.2.3 GETINGE 370
11.2.4 CONMED CORPORATION 371
11.2.5 TELEFLEX INCORPORATED 372
11.2.6 OLYMPUS CORPORATION 373
11.2.7 COOPERSURGICAL, INC. 374
11.2.8 APPLIED MEDICAL RESOURCES CORPORATION 375
11.2.9 OTU MEDICAL 376
11.2.10 ATMOS MEDIZINTECHNIK GMBH & CO. KG 377
12 APPENDIX 378
12.1 DISCUSSION GUIDE 378
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 386
12.3 CUSTOMIZATION OPTIONS 388
12.4 RELATED REPORTS 388
12.5 AUTHOR DETAILS 389
LIST OF TABLES
TABLE 1 MINIMALLY INVASIVE SURGERY MARKET: INCLUSIONS & EXCLUSIONS 36
TABLE 2 STANDARD CURRENCY CONVERSION RATES 38
TABLE 3 MINIMALLY INVASIVE SURGERY MARKET: STUDY ASSUMPTIONS 51
TABLE 4 MINIMALLY INVASIVE SURGERY MARKET: RISK ANALYSIS 52
TABLE 5 IMPORT DATA FOR HS CODE 9018, BY COUNTRY, 2019–2024 (USD THOUSAND) 70
TABLE 6 EXPORT DATA FOR HS CODE 9018, BY COUNTRY, 2019–2024 (USD THOUSAND) 70
TABLE 7 MINIMALLY INVASIVE SURGERY MARKET: PORTER’S FIVE FORCES 71
TABLE 8 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS FOR MINIMALLY INVASIVE SURGICAL PRODUCTS 74
TABLE 9 KEY BUYING CRITERIA FOR MAJOR MINIMALLY INVASIVE SURGICAL PRODUCTS 75
TABLE 10 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 75
TABLE 11 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 76
TABLE 12 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 76
TABLE 13 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 77
TABLE 14 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 77
TABLE 15 CLASSIFICATION OF MEDICAL DEVICES BY US FDA 78
TABLE 16 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 78
TABLE 17 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 79
TABLE 18 CLASSIFICATION OF MEDICAL DEVICES AND REVIEWING BODIES IN JAPAN 80
TABLE 19 NMPA MEDICAL DEVICES CLASSIFICATION 81
TABLE 20 AVERAGE SELLING PRICE TREND OF MINIMALLY INVASIVE SURGICAL PRODUCTS, BY KEY PLAYER, 2022–2024 (USD) 84
TABLE 21 AVERAGE SELLING PRICE TREND OF MINIMALLY INVASIVE SURGICAL PRODUCTS, BY REGION, 2022–2024 (USD) 85
TABLE 22 MINIMALLY INVASIVE SURGERY MARKET: DETAILED LIST OF KEY CONFERENCES & EVENTS, JANUARY 2025–DECEMBER 2026 86
TABLE 23 MINIMALLY INVASIVE SURGERY MARKET: UNMET NEEDS/END-USER EXPECTATIONS 87
TABLE 24 US-ADJUSTED RECIPROCAL TARIFF RATES 91
TABLE 25 KEY PRODUCT-RELATED TARIFF EFFECTIVE FOR ORTHODONTIC SUPPLIES 92
TABLE 26 MINIMALLY INVASIVE SURGERY MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 95
TABLE 27 MINIMALLY INVASIVE SURGICAL DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 96
TABLE 28 MINIMALLY INVASIVE SURGICAL DEVICES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 97
TABLE 29 HANDHELD INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 98
TABLE 30 HANDHELD INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 99
TABLE 31 TUBULAR RETRACTORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 100
TABLE 32 DILATORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 101
TABLE 33 SUTURING INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 102
TABLE 34 PROBES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 103
TABLE 35 LASER FIBER DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 104
TABLE 36 LAPAROSCOPY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 105
TABLE 37 LAPAROSCOPY DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 105
TABLE 38 LAPAROSCOPES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 106
TABLE 39 TROCARS & CANNULAS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 107
TABLE 40 GRASPERS & DISSECTORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 108
TABLE 41 INFLATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 109
TABLE 42 INFLATION SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 109
TABLE 43 BALLOON CATHETERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 110
TABLE 44 BALLON INFLATION SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 111
TABLE 45 GUIDING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 112
TABLE 46 GUIDING DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 112
TABLE 47 GUIDING CATHETERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 113
TABLE 48 GUIDEWIRES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 114
TABLE 49 MINIMALLY INVASIVE IMAGING & VISUALIZATION SYSTEMS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 115
TABLE 50 MINIMALLY INVASIVE IMAGING & VISUALIZATION SYSTEMS MARKET,
BY COUNTRY, 2023–2030 (USD MILLION) 116
TABLE 51 ULTRASOUND SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 117
TABLE 52 CT SCANNERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 119
TABLE 53 MRI SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 120
TABLE 54 X-RAY SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 121
TABLE 55 OTHER IMAGING & VISUALIZATION SYSTEMS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 122
TABLE 56 MINIMALLY INVASIVE ELECTROSURGICAL DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 123
TABLE 57 MINIMALLY INVASIVE ELECTROSURGICAL DEVICES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 124
TABLE 58 ELECTROCAUTERY DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 125
TABLE 59 ELECTROSURGICAL GENERATORS & ACCESSORIES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 126
TABLE 60 MINIMALLY INVASIVE ENDOSCOPY DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 127
TABLE 61 MINIMALLY INVASIVE ENDOSCOPY DEVICES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 127
TABLE 62 RIGID ENDOSCOPES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 128
TABLE 63 FLEXIBLE ENDOSCOPES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 129
TABLE 64 MINIMALLY INVASIVE MEDICAL ROBOTICS MARKET, BY TYPE,
2023–2030 (USD MILLION) 130
TABLE 65 MINIMALLY INVASIVE MEDICAL ROBOTICS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 131
TABLE 66 ROBOTIC SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 132
TABLE 67 ROBOTIC INTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 133
TABLE 68 ROBOTIC SOFTWARE & SERVICES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 134
TABLE 69 MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 136
TABLE 70 MINIMALLY INVASIVE GASTROINTESTINAL & ABDOMINAL SURGERY MARKET,
BY COUNTRY, 2023–2030 (USD MILLION) 137
TABLE 71 MINIMALLY INVASIVE CARDIOTHORACIC SURGERY MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 138
TABLE 72 MINIMALLY INVASIVE ORTHOPEDIC SURGERY MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 139
TABLE 73 MINIMALLY INVASIVE VASCULAR SURGERY MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 140
TABLE 74 MINIMALLY INVASIVE GYNECOLOGICAL SURGERY MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 141
TABLE 75 MINIMALLY INVASIVE ONCOLOGICAL SURGERY MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 142
TABLE 76 MINIMALLY INVASIVE NEUROLOGICAL SURGERY MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 143
TABLE 77 MINIMALLY INVASIVE UROLOGICAL SURGERY MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 144
TABLE 78 MINIMALLY INVASIVE ENT & RESPIRATORY SURGERY MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 145
TABLE 79 MINIMALLY INVASIVE COSMETIC SURGERY MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 146
TABLE 80 MINIMALLY INVASIVE DENTAL SURGERY MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 147
TABLE 81 MINIMALLY INVASIVE OTHER SURGERIES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 148
TABLE 82 MINIMALLY INVASIVE SURGERY MARKET, BY END USER,
2023–2030 (USD MILLION) 150
TABLE 83 MINIMALLY INVASIVE SURGERY MARKET FOR HOSPITALS, BY COUNTRY,
2023–2030 (USD MILLION) 151
TABLE 84 MINIMALLY INVASIVE SURGERY MARKET FOR AMBULATORY SURGERY CENTERS, BY COUNTRY, 2023–2030 (USD MILLION) 152
TABLE 85 MINIMALLY INVASIVE SURGERY MARKET FOR CLINICS, BY COUNTRY,
2023–2030 (USD MILLION) 153
TABLE 86 MINIMALLY INVASIVE SURGERY MARKET FOR EMERGENCY & TRAUMA CENTERS, BY COUNTRY, 2023–2030 (USD MILLION) 154
TABLE 87 MINIMALLY INVASIVE SURGERY MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION) 155
TABLE 88 MINIMALLY INVASIVE SURGERY MARKET, BY REGION, 2023–2030 (USD MILLION) 158
TABLE 89 MINIMALLY INVASIVE SURGERY MARKET, BY REGION,
2023–2030 (THOUSAND UNITS) 158
TABLE 90 NORTH AMERICA: MINIMALLY INVASIVE SURGERY MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 160
TABLE 91 NORTH AMERICA: MINIMALLY INVASIVE SURGERY MARKET, BY TYPE,
2023–2030 (THOUSAND UNITS) 161
TABLE 92 NORTH AMERICA: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 161
TABLE 93 NORTH AMERICA: MINIMALLY INVASIVE SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 162
TABLE 94 NORTH AMERICA: HANDHELD INSTRUMENTS MARKET, BY TYPE,
2023–2030 (USD MILLION) 162
TABLE 95 NORTH AMERICA: LAPAROSCOPY DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 162
TABLE 96 NORTH AMERICA: INFLATION SYSTEMS MARKET, BY TYPE,
2023–2030 (USD MILLION) 163
TABLE 97 NORTH AMERICA: GUIDING DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 163
TABLE 98 NORTH AMERICA: MINIMALLY INVASIVE IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 163
TABLE 99 NORTH AMERICA: MINIMALLY INVASIVE ELECTROSURGICAL DEVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 164
TABLE 100 NORTH AMERICA: MINIMALLY INVASIVE ENDOSCOPY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 164
TABLE 101 NORTH AMERICA: MINIMALLY INVASIVE MEDICAL ROBOTICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 164
TABLE 102 NORTH AMERICA: MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 165
TABLE 103 NORTH AMERICA: MINIMALLY INVASIVE SURGERY MARKET, BY END USER,
2023–2030 (USD MILLION) 165
TABLE 104 US: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 166
TABLE 105 US: MINIMALLY INVASIVE SURGICAL DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 167
TABLE 106 US: HANDHELD INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 167
TABLE 107 US: LAPAROSCOPY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 167
TABLE 108 US: INFLATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 168
TABLE 109 US: GUIDING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 168
TABLE 110 US: MINIMALLY INVASIVE IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 168
TABLE 111 US: MINIMALLY INVASIVE ELECTROSURGICAL DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 169
TABLE 112 US: MINIMALLY INVASIVE ENDOSCOPY DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 169
TABLE 113 US: MINIMALLY INVASIVE MEDICAL ROBOTICS MARKET, BY TYPE,
2023–2030 (USD MILLION) 169
TABLE 114 US: MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 170
TABLE 115 US: MINIMALLY INVASIVE SURGERY MARKET, BY END USER,
2023–2030 (USD MILLION) 170
TABLE 116 CANADA: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 171
TABLE 117 CANADA: MINIMALLY INVASIVE SURGICAL DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 171
TABLE 118 CANADA: HANDHELD INSTRUMENTS MARKET, BY TYPE,
2023–2030 (USD MILLION) 172
TABLE 119 CANADA: LAPAROSCOPY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 172
TABLE 120 CANADA: INFLATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 172
TABLE 121 CANADA: GUIDING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 173
TABLE 122 CANADA: MINIMALLY INVASIVE IMAGING & VISUALIZATION SYSTEMS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 173
TABLE 123 CANADA: MINIMALLY INVASIVE ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 173
TABLE 124 CANADA: MINIMALLY INVASIVE ENDOSCOPY DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 174
TABLE 125 CANADA: MINIMALLY INVASIVE MEDICAL ROBOTICS MARKET, BY TYPE,
2023–2030 (USD MILLION) 174
TABLE 126 CANADA: MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 175
TABLE 127 CANADA: MINIMALLY INVASIVE SURGERY MARKET, BY END USER,
2023–2030 (USD MILLION) 175
TABLE 128 EUROPE: MINIMALLY INVASIVE SURGERY MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 178
TABLE 129 EUROPE: MINIMALLY INVASIVE SURGERY MARKET, BY REGION,
2023–2030 (THOUSAND UNITS) 178
TABLE 130 EUROPE: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 179
TABLE 131 EUROPE: MINIMALLY INVASIVE SURGICAL DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 179
TABLE 132 EUROPE: HANDHELD INSTRUMENTS MARKET, BY TYPE,
2023–2030 (USD MILLION) 180
TABLE 133 EUROPE: LAPAROSCOPY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 180
TABLE 134 EUROPE: INFLATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 180
TABLE 135 EUROPE: GUIDING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 181
TABLE 136 EUROPE: MINIMALLY INVASIVE IMAGING & VISUALIZATION SYSTEMS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 181
TABLE 137 EUROPE: MINIMALLY INVASIVE ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 181
TABLE 138 EUROPE: MINIMALLY INVASIVE ENDOSCOPY DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 182
TABLE 139 EUROPE: MINIMALLY INVASIVE MEDICAL ROBOTICS MARKET, BY TYPE,
2023–2030 (USD MILLION) 182
TABLE 140 EUROPE: MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 183
TABLE 141 EUROPE: MINIMALLY INVASIVE SURGERY MARKET, BY END USER,
2023–2030 (USD MILLION) 183
TABLE 142 GERMANY: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 184
TABLE 143 GERMANY: MINIMALLY INVASIVE SURGICAL DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 184
TABLE 144 GERMANY: HANDHELD INSTRUMENTS MARKET, BY TYPE,
2023–2030 (USD MILLION) 185
TABLE 145 GERMANY: LAPAROSCOPY DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 185
TABLE 146 GERMANY: INFLATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 185
TABLE 147 GERMANY: GUIDING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 186
TABLE 148 GERMANY: MINIMALLY INVASIVE IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 186
TABLE 149 GERMANY: MINIMALLY INVASIVE ELECTROSURGICAL DEVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 186
TABLE 150 GERMANY: MINIMALLY INVASIVE ENDOSCOPY DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 187
TABLE 151 GERMANY: MINIMALLY INVASIVE MEDICAL ROBOTICS MARKET, BY TYPE,
2023–2030 (USD MILLION) 187
TABLE 152 GERMANY: MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 188
TABLE 153 GERMANY: MINIMALLY INVASIVE SURGERY MARKET, BY END USER,
2023–2030 (USD MILLION) 188
TABLE 154 UK: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 189
TABLE 155 UK: MINIMALLY INVASIVE SURGICAL DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 189
TABLE 156 UK: HANDHELD INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 190
TABLE 157 UK: LAPAROSCOPY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 190
TABLE 158 UK: INFLATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 190
TABLE 159 UK: GUIDING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 191
TABLE 160 UK: MINIMALLY INVASIVE IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 191
TABLE 161 UK: MINIMALLY INVASIVE ELECTROSURGICAL DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 191
TABLE 162 UK: MINIMALLY INVASIVE ENDOSCOPY DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 192
TABLE 163 UK: MINIMALLY INVASIVE MEDICAL ROBOTICS MARKET, BY TYPE,
2023–2030 (USD MILLION) 192
TABLE 164 UK: MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 193
TABLE 165 UK: MINIMALLY INVASIVE SURGERY MARKET, BY END USER,
2023–2030 (USD MILLION) 193
TABLE 166 FRANCE: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 194
TABLE 167 FRANCE: MINIMALLY INVASIVE SURGICAL DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 194
TABLE 168 FRANCE: HANDHELD INSTRUMENTS MARKET, BY TYPE,
2023–2030 (USD MILLION) 195
TABLE 169 FRANCE: LAPAROSCOPY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 195
TABLE 170 FRANCE: INFLATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 195
TABLE 171 FRANCE: GUIDING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 196
TABLE 172 FRANCE: MINIMALLY INVASIVE IMAGING & VISUALIZATION SYSTEMS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 196
TABLE 173 FRANCE: MINIMALLY INVASIVE ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 196
TABLE 174 FRANCE: MINIMALLY INVASIVE ENDOSCOPY DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 197
TABLE 175 FRANCE: MINIMALLY INVASIVE MEDICAL ROBOTICS MARKET, BY TYPE,
2023–2030 (USD MILLION) 197
TABLE 176 FRANCE: MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 198
TABLE 177 FRANCE: MINIMALLY INVASIVE SURGERY MARKET, BY END USER,
2023–2030 (USD MILLION) 198
TABLE 178 ITALY: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 199
TABLE 179 ITALY: MINIMALLY INVASIVE SURGICAL DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 199
TABLE 180 ITALY: HANDHELD INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 200
TABLE 181 ITALY: LAPAROSCOPY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 200
TABLE 182 ITALY: INFLATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 200
TABLE 183 ITALY: GUIDING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 201
TABLE 184 ITALY: MINIMALLY INVASIVE IMAGING & VISUALIZATION SYSTEMS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 201
TABLE 185 ITALY: MINIMALLY INVASIVE ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 201
TABLE 186 ITALY: MINIMALLY INVASIVE ENDOSCOPY DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 202
TABLE 187 ITALY: MINIMALLY INVASIVE MEDICAL ROBOTICS MARKET, BY TYPE,
2023–2030 (USD MILLION) 202
TABLE 188 ITALY: MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 203
TABLE 189 ITALY: MINIMALLY INVASIVE SURGERY MARKET, BY END USER,
2023–2030 (USD MILLION) 203
TABLE 190 SPAIN: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 204
TABLE 191 SPAIN: MINIMALLY INVASIVE SURGICAL DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 204
TABLE 192 SPAIN: HANDHELD INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 205
TABLE 193 SPAIN: LAPAROSCOPY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 205
TABLE 194 SPAIN: INFLATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 205
TABLE 195 SPAIN: GUIDING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 206
TABLE 196 SPAIN: MINIMALLY INVASIVE IMAGING & VISUALIZATION SYSTEMS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 206
TABLE 197 SPAIN: MINIMALLY INVASIVE ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 206
TABLE 198 SPAIN: MINIMALLY INVASIVE ENDOSCOPY DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 207
TABLE 199 SPAIN: MINIMALLY INVASIVE MEDICAL ROBOTICS MARKET, BY TYPE,
2023–2030 (USD MILLION) 207
TABLE 200 SPAIN: MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 208
TABLE 201 SPAIN: MINIMALLY INVASIVE SURGERY MARKET, BY END USER,
2023–2030 (USD MILLION) 208
TABLE 202 REST OF EUROPE: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 209
TABLE 203 REST OF EUROPE: MINIMALLY INVASIVE SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 209
TABLE 204 REST OF EUROPE: HANDHELD INSTRUMENTS MARKET, BY TYPE,
2023–2030 (USD MILLION) 210
TABLE 205 REST OF EUROPE: LAPAROSCOPY DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 210
TABLE 206 REST OF EUROPE: INFLATION SYSTEMS MARKET, BY TYPE,
2023–2030 (USD MILLION) 210
TABLE 207 REST OF EUROPE: GUIDING DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 211
TABLE 208 REST OF EUROPE: MINIMALLY INVASIVE IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 211
TABLE 209 REST OF EUROPE: MINIMALLY INVASIVE ELECTROSURGICAL DEVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 211
TABLE 210 REST OF EUROPE: MINIMALLY INVASIVE ENDOSCOPY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 212
TABLE 211 REST OF EUROPE: MINIMALLY INVASIVE MEDICAL ROBOTICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 212
TABLE 212 REST OF EUROPE: MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 213
TABLE 213 REST OF EUROPE: MINIMALLY INVASIVE SURGERY MARKET, BY END USER,
2023–2030 (USD MILLION) 213
TABLE 214 ASIA PACIFIC: MINIMALLY INVASIVE SURGERY MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 214
TABLE 215 ASIA PACIFIC: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT,
2023–2030 (THOUSAND UNITS) 215
TABLE 216 ASIA PACIFIC: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 215
TABLE 217 ASIA PACIFIC: MINIMALLY INVASIVE SURGICAL DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 216
TABLE 218 ASIA PACIFIC: HANDHELD INSTRUMENTS MARKET, BY TYPE,
2023–2030 (USD MILLION) 216
TABLE 219 ASIA PACIFIC: LAPAROSCOPY DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 216
TABLE 220 ASIA PACIFIC: INFLATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 217
TABLE 221 ASIA PACIFIC: GUIDING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 217
TABLE 222 ASIA PACIFIC: MINIMALLY INVASIVE IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 217
TABLE 223 ASIA PACIFIC: MINIMALLY INVASIVE ELECTROSURGICAL DEVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 218
TABLE 224 ASIA PACIFIC: MINIMALLY INVASIVE ENDOSCOPY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 218
TABLE 225 ASIA PACIFIC: MINIMALLY INVASIVE MEDICAL ROBOTICS MARKET, BY TYPE,
2023–2030 (USD MILLION) 218
TABLE 226 ASIA PACIFIC: MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 219
TABLE 227 ASIA PACIFIC: MINIMALLY INVASIVE SURGERY MARKET, BY END USER,
2023–2030 (USD MILLION) 219
TABLE 228 CHINA: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 220
TABLE 229 CHINA: MINIMALLY INVASIVE SURGICAL DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 221
TABLE 230 CHINA: HANDHELD INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 221
TABLE 231 CHINA: LAPAROSCOPY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 221
TABLE 232 CHINA: INFLATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 222
TABLE 233 CHINA: GUIDING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 222
TABLE 234 CHINA: MINIMALLY INVASIVE IMAGING & VISUALIZATION SYSTEMS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 222
TABLE 235 CHINA: MINIMALLY INVASIVE ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 223
TABLE 236 CHINA: MINIMALLY INVASIVE ENDOSCOPY DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 223
TABLE 237 CHINA: MINIMALLY INVASIVE MEDICAL ROBOTICS MARKET, BY TYPE,
2023–2030 (USD MILLION) 223
TABLE 238 CHINA: MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 224
TABLE 239 CHINA: MINIMALLY INVASIVE SURGERY MARKET, BY END USER,
2023–2030 (USD MILLION) 224
TABLE 240 INDIA: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 225
TABLE 241 INDIA: MINIMALLY INVASIVE SURGICAL DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 225
TABLE 242 INDIA: HANDHELD INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 226
TABLE 243 INDIA: LAPAROSCOPY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 226
TABLE 244 INDIA: INFLATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 226
TABLE 245 INDIA: GUIDING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 227
TABLE 246 INDIA: MINIMALLY INVASIVE IMAGING & VISUALIZATION SYSTEMS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 227
TABLE 247 INDIA: MINIMALLY INVASIVE ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 227
TABLE 248 INDIA: MINIMALLY INVASIVE ENDOSCOPY DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 228
TABLE 249 INDIA: MINIMALLY INVASIVE MEDICAL ROBOTICS MARKET, BY TYPE,
2023–2030 (USD MILLION) 228
TABLE 250 INDIA: MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 229
TABLE 251 INDIA: MINIMALLY INVASIVE SURGERY MARKET, BY END USER,
2023–2030 (USD MILLION) 229
TABLE 252 JAPAN: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 230
TABLE 253 JAPAN: MINIMALLY INVASIVE SURGICAL DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 230
TABLE 254 JAPAN: HANDHELD INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 231
TABLE 255 JAPAN: LAPAROSCOPY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 231
TABLE 256 JAPAN: INFLATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 231
TABLE 257 JAPAN: GUIDING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 232
TABLE 258 JAPAN: MINIMALLY INVASIVE IMAGING & VISUALIZATION SYSTEMS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 232
TABLE 259 JAPAN: MINIMALLY INVASIVE ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 232
TABLE 260 JAPAN: MINIMALLY INVASIVE ENDOSCOPY DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 233
TABLE 261 JAPAN: MINIMALLY INVASIVE MEDICAL ROBOTICS MARKET, BY TYPE,
2023–2030 (USD MILLION) 233
TABLE 262 JAPAN: MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 234
TABLE 263 JAPAN: MINIMALLY INVASIVE SURGERY MARKET, BY END USER,
2023–2030 (USD MILLION) 234
TABLE 264 SOUTH KOREA: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 235
TABLE 265 SOUTH KOREA: MINIMALLY INVASIVE SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 235
TABLE 266 SOUTH KOREA: HANDHELD INSTRUMENTS MARKET, BY TYPE,
2023–2030 (USD MILLION) 236
TABLE 267 SOUTH KOREA: LAPAROSCOPY DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 236
TABLE 268 SOUTH KOREA: INFLATION SYSTEMS MARKET, BY TYPE,
2023–2030 (USD MILLION) 236
TABLE 269 SOUTH KOREA: GUIDING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 237
TABLE 270 SOUTH KOREA: MINIMALLY INVASIVE IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 237
TABLE 271 SOUTH KOREA: MINIMALLY INVASIVE ELECTROSURGICAL DEVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 237
TABLE 272 SOUTH KOREA: MINIMALLY INVASIVE ENDOSCOPY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 238
TABLE 273 SOUTH KOREA: MINIMALLY INVASIVE MEDICAL ROBOTICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 238
TABLE 274 SOUTH KOREA: MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 239
TABLE 275 SOUTH KOREA: MINIMALLY INVASIVE SURGERY MARKET, BY END USER,
2023–2030 (USD MILLION) 239
TABLE 276 AUSTRALIA: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 240
TABLE 277 AUSTRALIA: MINIMALLY INVASIVE SURGICAL DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 240
TABLE 278 AUSTRALIA: HANDHELD INSTRUMENTS MARKET, BY TYPE,
2023–2030 (USD MILLION) 241
TABLE 279 AUSTRALIA: LAPAROSCOPY DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 241
TABLE 280 AUSTRALIA: INFLATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 241
TABLE 281 AUSTRALIA: GUIDING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 242
TABLE 282 AUSTRALIA: MINIMALLY INVASIVE IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 242
TABLE 283 AUSTRALIA: MINIMALLY INVASIVE ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 242
TABLE 284 AUSTRALIA: MINIMALLY INVASIVE ENDOSCOPY DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 243
TABLE 285 AUSTRALIA: MINIMALLY INVASIVE MEDICAL ROBOTICS MARKET, BY TYPE,
2023–2030 (USD MILLION) 243
TABLE 286 AUSTRALIA: MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 244
TABLE 287 AUSTRALIA: MINIMALLY INVASIVE SURGERY MARKET, BY END USER,
2023–2030 (USD MILLION) 244
TABLE 288 REST OF ASIA PACIFIC: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 245
TABLE 289 REST OF ASIA PACIFIC: MINIMALLY INVASIVE SURGICAL DEVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 245
TABLE 290 REST OF ASIA PACIFIC: HANDHELD INSTRUMENTS MARKET, BY TYPE,
2023–2030 (USD MILLION) 246
TABLE 291 REST OF ASIA PACIFIC: LAPAROSCOPY DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 246
TABLE 292 REST OF ASIA PACIFIC: INFLATION SYSTEMS MARKET, BY TYPE,
2023–2030 (USD MILLION) 246
TABLE 293 REST OF ASIA PACIFIC: GUIDING DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 247
TABLE 294 REST OF ASIA PACIFIC: MINIMALLY INVASIVE IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 247
TABLE 295 REST OF ASIA PACIFIC: MINIMALLY INVASIVE ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 247
TABLE 296 REST OF ASIA PACIFIC: MINIMALLY INVASIVE ENDOSCOPY DEVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 248
TABLE 297 REST OF ASIA PACIFIC: MINIMALLY INVASIVE MEDICAL ROBOTICS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 248
TABLE 298 REST OF ASIA PACIFIC: MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 249
TABLE 299 REST OF ASIA PACIFIC: MINIMALLY INVASIVE SURGERY MARKET, BY END USER, 2023–2030 (USD MILLION) 249
TABLE 300 LATIN AMERICA: MINIMALLY INVASIVE SURGERY MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 250
TABLE 301 LATIN AMERICA: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT,
2023–2030 (THOUSAND UNITS) 251
TABLE 302 LATIN AMERICA: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 251
TABLE 303 LATIN AMERICA: MINIMALLY INVASIVE SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 252
TABLE 304 LATIN AMERICA: HANDHELD INSTRUMENTS MARKET, BY TYPE,
2023–2030 (USD MILLION) 252
TABLE 305 LATIN AMERICA: LAPAROSCOPY DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 252
TABLE 306 LATIN AMERICA: INFLATION SYSTEMS MARKET, BY TYPE,
2023–2030 (USD MILLION) 253
TABLE 307 LATIN AMERICA: GUIDING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 253
TABLE 308 LATIN AMERICA: MINIMALLY INVASIVE IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 253
TABLE 309 LATIN AMERICA: MINIMALLY INVASIVE ELECTROSURGICAL DEVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 254
TABLE 310 LATIN AMERICA: MINIMALLY INVASIVE ENDOSCOPY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 254
TABLE 311 LATIN AMERICA: MINIMALLY INVASIVE MEDICAL ROBOTICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 254
TABLE 312 LATIN AMERICA: MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 255
TABLE 313 LATIN AMERICA: MINIMALLY INVASIVE SURGERY MARKET, BY END USER,
2023–2030 (USD MILLION) 256
TABLE 314 BRAZIL: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 256
TABLE 315 BRAZIL: MINIMALLY INVASIVE SURGICAL DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 257
TABLE 316 BRAZIL: HANDHELD INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 257
TABLE 317 BRAZIL: LAPAROSCOPY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 257
TABLE 318 BRAZIL: INFLATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 258
TABLE 319 BRAZIL: GUIDING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 258
TABLE 320 BRAZIL: MINIMALLY INVASIVE IMAGING & VISUALIZATION SYSTEMS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 258
TABLE 321 BRAZIL: MINIMALLY INVASIVE ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 259
TABLE 322 BRAZIL: MINIMALLY INVASIVE ENDOSCOPY DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 259
TABLE 323 BRAZIL: MINIMALLY INVASIVE MEDICAL ROBOTICS MARKET, BY TYPE,
2023–2030 (USD MILLION) 259
TABLE 324 BRAZIL: MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 260
TABLE 325 BRAZIL: MINIMALLY INVASIVE SURGERY MARKET, BY END USER,
2023–2030 (USD MILLION) 260
TABLE 326 MEXICO: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 261
TABLE 327 MEXICO: MINIMALLY INVASIVE SURGICAL DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 261
TABLE 328 MEXICO: HANDHELD INSTRUMENTS MARKET, BY TYPE,
2023–2030 (USD MILLION) 262
TABLE 329 MEXICO: LAPAROSCOPY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 262
TABLE 330 MEXICO: INFLATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 262
TABLE 331 MEXICO: GUIDING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 263
TABLE 332 MEXICO: MINIMALLY INVASIVE IMAGING & VISUALIZATION SYSTEMS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 263
TABLE 333 MEXICO: MINIMALLY INVASIVE ELECTROSURGICAL DEVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 263
TABLE 334 MEXICO: MINIMALLY INVASIVE ENDOSCOPY DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 264
TABLE 335 MEXICO: MINIMALLY INVASIVE MEDICAL ROBOTICS MARKET, BY TYPE,
2023–2030 (USD MILLION) 264
TABLE 336 MEXICO: MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 265
TABLE 337 MEXICO: MINIMALLY INVASIVE SURGERY MARKET, BY END USER,
2023–2030 (USD MILLION) 265
TABLE 338 REST OF LATIN AMERICA: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 266
TABLE 339 REST OF LATIN AMERICA: MINIMALLY INVASIVE SURGICAL DEVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 266
TABLE 340 REST OF LATIN AMERICA: HANDHELD INSTRUMENTS MARKET, BY TYPE,
2023–2030 (USD MILLION) 267
TABLE 341 REST OF LATIN AMERICA: LAPAROSCOPY DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 267
TABLE 342 REST OF LATIN AMERICA: INFLATION SYSTEMS MARKET, BY TYPE,
2023–2030 (USD MILLION) 267
TABLE 343 REST OF LATIN AMERICA: GUIDING DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 268
TABLE 344 REST OF LATIN AMERICA: MINIMALLY INVASIVE IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 268
TABLE 345 REST OF LATIN AMERICA: MINIMALLY INVASIVE ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 268
TABLE 346 REST OF LATIN AMERICA: MINIMALLY INVASIVE ENDOSCOPY DEVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 269
TABLE 347 REST OF LATIN AMERICA: MINIMALLY INVASIVE MEDICAL ROBOTICS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 269
TABLE 348 REST OF LATIN AMERICA: MINIMALLY INVASIVE SURGERY MARKET,
BY APPLICATION, 2023–2030 (USD MILLION) 270
TABLE 349 REST OF LATIN AMERICA: MINIMALLY INVASIVE SURGERY MARKET,
BY END USER, 2023–2030 (USD MILLION) 270
TABLE 350 MIDDLE EAST & AFRICA: MINIMALLY INVASIVE SURGERY MARKET,
BY COUNTRY, 2023–2030 (USD MILLION) 271
TABLE 351 MIDDLE EAST & AFRICA: MINIMALLY INVASIVE SURGERY MARKET,
BY REGION, 2023–2030 (THOUSAND UNITS) 272
TABLE 352 MIDDLE EAST & AFRICA: MINIMALLY INVASIVE SURGERY MARKET,
BY PRODUCT, 2023–2030 (USD MILLION) 272
TABLE 353 MIDDLE EAST & AFRICA: MINIMALLY INVASIVE SURGICAL DEVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 273
TABLE 354 MIDDLE EAST & AFRICA: HANDHELD INSTRUMENTS MARKET, BY TYPE,
2023–2030 (USD MILLION) 273
TABLE 355 MIDDLE EAST & AFRICA: LAPAROSCOPY DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 274
TABLE 356 MIDDLE EAST & AFRICA: INFLATION SYSTEMS MARKET, BY TYPE,
2023–2030 (USD MILLION) 274
TABLE 357 MIDDLE EAST & AFRICA: GUIDING DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 274
TABLE 358 MIDDLE EAST & AFRICA: MINIMALLY INVASIVE IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 275
TABLE 359 MIDDLE EAST & AFRICA: MINIMALLY INVASIVE ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 275
TABLE 360 MIDDLE EAST & AFRICA: MINIMALLY INVASIVE ENDOSCOPY DEVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 275
TABLE 361 MIDDLE EAST & AFRICA: MINIMALLY INVASIVE MEDICAL ROBOTICS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 276
TABLE 362 MIDDLE EAST & AFRICA: MINIMALLY INVASIVE SURGERY MARKET,
BY APPLICATION, 2023–2030 (USD MILLION) 276
TABLE 363 MIDDLE EAST & AFRICA: MINIMALLY INVASIVE SURGERY MARKET,
BY END USER, 2023–2030 (USD MILLION) 277
TABLE 364 GCC COUNTRIES: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 278
TABLE 365 GCC COUNTRIES: MINIMALLY INVASIVE SURGICAL DEVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 278
TABLE 366 GCC COUNTRIES: HANDHELD INSTRUMENTS MARKET, BY TYPE,
2023–2030 (USD MILLION) 279
TABLE 367 GCC COUNTRIES: LAPAROSCOPY DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 279
TABLE 368 GCC COUNTRIES: INFLATION SYSTEMS MARKET, BY TYPE,
2023–2030 (USD MILLION) 279
TABLE 369 GCC COUNTRIES: GUIDING DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 280
TABLE 370 GCC COUNTRIES: MINIMALLY INVASIVE IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 280
TABLE 371 GCC COUNTRIES: MINIMALLY INVASIVE ELECTROSURGICAL DEVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 280
TABLE 372 GCC COUNTRIES: MINIMALLY INVASIVE ENDOSCOPY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 281
TABLE 373 GCC COUNTRIES: MINIMALLY INVASIVE MEDICAL ROBOTICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 281
TABLE 374 GCC COUNTRIES: MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 282
TABLE 375 GCC COUNTRIES: MINIMALLY INVASIVE SURGERY MARKET, BY END USER,
2023–2030 (USD MILLION) 282
TABLE 376 REST OF MIDDLE EAST & AFRICA: MINIMALLY INVASIVE SURGERY MARKET,
BY PRODUCT, 2023–2030 (USD MILLION) 283
TABLE 377 REST OF MIDDLE EAST & AFRICA: MINIMALLY INVASIVE SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 283
TABLE 378 REST OF MIDDLE EAST & AFRICA: HANDHELD INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 284
TABLE 379 REST OF MIDDLE EAST & AFRICA: LAPAROSCOPY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 284
TABLE 380 REST OF MIDDLE EAST & AFRICA: INFLATION SYSTEMS MARKET, BY TYPE,
2023–2030 (USD MILLION) 284
TABLE 381 REST OF MIDDLE EAST & AFRICA: GUIDING DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 285
TABLE 382 REST OF MIDDLE EAST & AFRICA: MINIMALLY INVASIVE IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 285
TABLE 383 REST OF MIDDLE EAST & AFRICA: MINIMALLY INVASIVE ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 285
TABLE 384 REST OF MIDDLE EAST & AFRICA: MINIMALLY INVASIVE ENDOSCOPY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 286
TABLE 385 REST OF MIDDLE EAST & AFRICA: MINIMALLY INVASIVE MEDICAL ROBOTICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 286
TABLE 386 REST OF MIDDLE EAST & AFRICA: MINIMALLY INVASIVE SURGERY MARKET,
BY APPLICATION, 2023–2030 (USD MILLION) 287
TABLE 387 REST OF MIDDLE EAST & AFRICA: MINIMALLY INVASIVE SURGERY MARKET,
BY END USER, 2023–2030 (USD MILLION) 287
TABLE 388 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN MINIMALLY INVASIVE SURGERY MARKET 288
TABLE 389 MINIMALLY INVASIVE SURGERY MARKET: DEGREE OF COMPETITION 291
TABLE 390 MINIMALLY INVASIVE SURGERY MARKET: REGION FOOTPRINT 296
TABLE 391 MINIMALLY INVASIVE SURGERY MARKET: PRODUCT FOOTPRINT 297
TABLE 392 MINIMALLY INVASIVE SURGERY MARKET: APPLICATION FOOTPRINT 298
TABLE 393 MINIMALLY INVASIVE SURGERY MARKET: END-USER FOOTPRINT 299
TABLE 394 MINIMALLY INVASIVE SURGERY MARKET: DETAILED LIST OF KEY
STARTUPS/SME PLAYERS 302
TABLE 395 MINIMALLY INVASIVE SURGERY MARKET: COMPETITIVE BENCHMARKING
OF KEY STARTUPS/SME PLAYERS, BY PRODUCT AND REGION 302
TABLE 396 MINIMALLY INVASIVE SURGERY MARKET: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022–JULY 2025 305
TABLE 397 MINIMALLY INVASIVE SURGERY MARKET: DEALS, JANUARY 2022–JULY 2025 306
TABLE 398 MEDTRONIC: COMPANY OVERVIEW 307
TABLE 399 MEDTRONIC: PRODUCTS OFFERED 308
TABLE 400 MEDTRONIC: PRODUCT APPROVALS, JANUARY 2022–JULY 2025 313
TABLE 401 MEDTRONIC: EXPANSIONS, JANUARY 2022–JULY 2025 313
TABLE 402 JOHNSON & JOHNSON: COMPANY OVERVIEW 315
TABLE 403 JOHNSON & JOHNSON: PRODUCTS OFFERED 316
TABLE 404 JOHNSON & JOHNSON: PRODUCT APPROVALS, JANUARY 2022–JULY 2025 318
TABLE 405 JOHNSON & JOHNSON: DEALS, JANUARY 2022–JULY 2025 318
TABLE 406 STRYKER: COMPANY OVERVIEW 320
TABLE 407 STRYKER: PRODUCTS OFFERED 321
TABLE 408 STRYKER: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022–JULY 2025 323
TABLE 409 STRYKER: DEALS, JANUARY 2022–JULY 2025 324
TABLE 410 BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW 325
TABLE 411 BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED 326
TABLE 412 BOSTON SCIENTIFIC CORPORATION: DEALS, JANUARY 2022–JULY 2025 327
TABLE 413 ABBOTT: COMPANY OVERVIEW 330
TABLE 414 ABBOTT: PRODUCTS OFFERED 331
TABLE 415 ABBOTT: DEALS, JANUARY 2022–JULY 2025 332
TABLE 416 ZIMMER BIOMET: COMPANY OVERVIEW 333
TABLE 417 ZIMMER BIOMET: PRODUCTS OFFERED 334
TABLE 418 ZIMMER BIOMET: PRODUCT APPROVALS, JANUARY 2022–JULY 2025 335
TABLE 419 ZIMMER BIOMET: DEALS, JANUARY 2022–JULY 2025 335
TABLE 420 B. BRAUN SE: COMPANY OVERVIEW 336
TABLE 421 B BRAUN SE: PRODUCTS OFFERED 337
TABLE 422 GLOBUS MEDICAL: COMPANY OVERVIEW 339
TABLE 423 GLOBUS MEDICAL: PRODUCTS OFFERED 340
TABLE 424 GLOBUS MEDICAL: DEALS, JANUARY 2022–JULY 2025 341
TABLE 425 INTEGRA LIFESCIENCES CORPORATION: COMPANY OVERVIEW 342
TABLE 426 INTEGRA LIFESCIENCES CORPORATION: PRODUCTS OFFERED 343
TABLE 427 SIEMENS HEALTHINEERS AG: COMPANY OVERVIEW 344
TABLE 428 SIEMENS HEALTHINEERS AG: PRODUCTS OFFERED 345
TABLE 429 SIEMENS HEALTHINEERS AG: PRODUCT LAUNCHES, JANUARY 2022–JULY 2025 347
TABLE 430 SIEMENS HEALTHINEERS AG: EXPANSIONS, JANUARY 2022–JULY 2025 348
TABLE 431 FUJIFILM CORPORATION: COMPANY OVERVIEW 349
TABLE 432 FUJIFILM CORPORATION: PRODUCTS OFFERED 350
TABLE 433 FUJIFILM CORPORATION: PRODUCT LAUNCHES AND APPROVALS,
JANUARY 2022–JULY 2025 352
TABLE 434 FUJIFILM CORPORATION: DEALS, JANUARY 2022–JULY 2025 352
TABLE 435 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW 353
TABLE 436 KONINKLIJKE PHILIPS N.V.: PRODUCTS OFFERED 354
TABLE 437 KONINKLIJKE PHILIPS N.V.: PRODUCT LAUNCHES AND APPROVALS,
JANUARY 2022–JULY 2025 356
TABLE 438 KONINKLIJKE PHILIPS N.V.: DEALS, JANUARY 2022–JULY 2025 357
TABLE 439 INTUITIVE SURGICAL OPERATIONS, INC.: COMPANY OVERVIEW 358
TABLE 440 INTUITIVE SURGICAL OPERATIONS, INC.: PRODUCTS OFFERED 359
TABLE 441 INTUITIVE SURGICAL OPERATIONS, INC.: PRODUCT APPROVALS,
JANUARY 2022–JULY 2025 360
TABLE 442 KARL STORZ SE & CO. KG: COMPANY OVERVIEW 361
TABLE 443 KARL STORZ SE & CO. KG: PRODUCTS OFFERED 361
TABLE 444 KARL STORZ SE & CO. KG: DEALS, JANUARY 2022–JULY 2025 363
TABLE 445 KARL STORZ SE & CO. KG: EXPANSIONS, JANUARY 2022–JULY 2025 363
TABLE 446 GE HEALTHCARE: COMPANY OVERVIEW 364
TABLE 447 GE HEALTHCARE: PRODUCTS OFFERED 365
TABLE 448 GE HEALTHCARE: PRODUCT LAUNCHES, JANUARY 2022–JULY 2025 367
TABLE 449 GE HEALTHCARE: DEALS, JANUARY 2022–JULY 2025 367
TABLE 450 NIPRO: COMPANY OVERVIEW 368
TABLE 451 SMITH+NEPHEW: COMPANY OVERVIEW 369
TABLE 452 GETINGE: COMPANY OVERVIEW 370
TABLE 453 CONMED CORPORATION: COMPANY OVERVIEW 371
TABLE 454 TELEFLEX INCORPORATED: COMPANY OVERVIEW 372
TABLE 455 OLYMPUS CORPORATION: COMPANY OVERVIEW 373
TABLE 456 COOPERSURGICAL, INC.: COMPANY OVERVIEW 374
TABLE 457 APPLIED MEDICAL RESOURCES CORPORATION: COMPANY OVERVIEW 375
TABLE 458 OTU MEDICAL: COMPANY OVERVIEW 376
TABLE 459 ATMOS MEDIZINTECHNIK GMBH & CO. KG: COMPANY OVERVIEW 377
LIST OF FIGURES
FIGURE 1 MINIMALLY INVASIVE SURGERY MARKET SEGMENTATION & REGIONAL SCOPE 35
FIGURE 2 MINIMALLY INVASIVE SURGERY MARKET: YEARS CONSIDERED 37
FIGURE 3 MINIMALLY INVASIVE SURGERY MARKET: RESEARCH DESIGN 40
FIGURE 4 MINIMALLY INVASIVE SURGERY MARKET: KEY DATA FROM SECONDARY SOURCES 42
FIGURE 5 MINIMALLY INVASIVE SURGERY MARKET: KEY PRIMARY SOURCES 43
FIGURE 6 MINIMALLY INVASIVE SURGERY MARKET: KEY DATA FROM PRIMARY SOURCES 44
FIGURE 7 MINIMALLY INVASIVE SURGERY MARKET: KEY INSIGHTS
FROM INDUSTRY EXPERTS 45
FIGURE 8 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE,
DESIGNATION, AND REGION 45
FIGURE 9 MINIMALLY INVASIVE SURGERY MARKET SIZE APPROACH:
REVENUE SHARE ANALYSIS 46
FIGURE 10 MINIMALLY INVASIVE SURGERY MARKET: TOP-DOWN APPROACH 47
FIGURE 11 IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN MINIMALLY INVASIVE SURGERY MARKET (2025–2030) 48
FIGURE 12 MINIMALLY INVASIVE SURGERY MARKET: CAGR PROJECTIONS 49
FIGURE 13 MINIMALLY INVASIVE SURGERY MARKET: DATA TRIANGULATION METHODOLOGY 50
FIGURE 14 MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT,
2025 VS. 2030 (USD MILLION) 53
FIGURE 15 MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION,
2025 VS. 2030 (USD MILLION) 54
FIGURE 16 MINIMALLY INVASIVE SURGERY MARKET, BY END USER,
2025 VS. 2030 (USD MILLION) 55
FIGURE 17 MINIMALLY INVASIVE SURGERY MARKET: REGIONAL SNAPSHOT 56
FIGURE 18 HIGH VOLUME OF SURGICAL PROCEDURES AND PREFERENCE FOR MINIMALLY INVASIVE SURGICAL PROCEDURES TO DRIVE MARKET 57
FIGURE 19 US AND HOSPITALS SEGMENT COMMANDED LARGEST MARKET SHARE IN 2024 58
FIGURE 20 CHINA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD 59
FIGURE 21 NORTH AMERICA TO GROW AT HIGHEST GROWTH RATE FROM 2025 TO 2030 59
FIGURE 22 EMERGING MARKETS TO REGISTER HIGHER GROWTH RATES
DURING STUDY PERIOD 60
FIGURE 23 MINIMALLY INVASIVE SURGERY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 61
FIGURE 24 MINIMALLY INVASIVE SURGERY MARKET: VALUE CHAIN ANALYSIS 67
FIGURE 25 MINIMALLY INVASIVE SURGERY MARKET: ECOSYSTEM ANALYSIS 68
FIGURE 26 MINIMALLY INVASIVE SURGERY MARKET: SUPPLY CHAIN ANALYSIS 69
FIGURE 27 MINIMALLY INVASIVE SURGERY MARKET: PORTER’S FIVE FORCES ANALYSIS 71
FIGURE 28 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS FOR MINIMALLY INVASIVE SURGICAL PRODUCTS 73
FIGURE 29 KEY BUYING CRITERIA FOR MAJOR MINIMALLY INVASIVE SURGICAL PRODUCTS 74
FIGURE 30 TOP 10 COMPANIES WITH HIGHEST PATENT OWNERSHIPS/APPLICATIONS AND NUMBER OF PATENTS GRANTED (JANUARY 2015–JULY 2025) 82
FIGURE 31 TOP APPLICANT COUNTRIES/REGIONS FOR MINIMALLY INVASIVE SURGERY PATENTS (JANUARY 2014−MAY 2025) 83
FIGURE 32 ENDOSCOPY EQUIPMENT MARKET OVERVIEW 87
FIGURE 33 MINIMALLY INVASIVE SURGERY MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS 88
FIGURE 34 MINIMALLY INVASIVE SURGERY MARKET: FUNDING AND NUMBER
OF DEALS (2019–2023) 89
FIGURE 35 IMPACT OF AI/GEN AI ON MINIMALLY INVASIVE SURGERY MARKET 90
FIGURE 36 MINIMALLY INVASIVE SURGERY MARKET: GEOGRAPHIC SNAPSHOT 157
FIGURE 37 NORTH AMERICA: MINIMALLY INVASIVE SURGERY MARKET SNAPSHOT 160
FIGURE 38 EUROPE: MINIMALLY INVASIVE SURGERY MARKET SNAPSHOT 177
FIGURE 39 REVENUE ANALYSIS OF KEY PLAYERS IN MINIMALLY INVASIVE
SURGERY MARKET (2022–2024) 290
FIGURE 40 MARKET SHARE ANALYSIS OF KEY PLAYERS IN MINIMALLY
INVASIVE SURGERY MARKET (2024) 291
FIGURE 41 MINIMALLY INVASIVE SURGERY MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024 294
FIGURE 42 MINIMALLY INVASIVE SURGERY MARKET: COMPANY FOOTPRINT 295
FIGURE 43 MINIMALLY INVASIVE SURGERY MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 301
FIGURE 44 EV/EBITDA OF KEY VENDORS 303
FIGURE 45 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK
BETA OF KEY VENDORS 303
FIGURE 46 MINIMALLY INVASIVE SURGERY MARKET: BRAND/PRODUCT
COMPARATIVE ANALYSIS 304
FIGURE 47 MEDTRONIC: COMPANY SNAPSHOT 308
FIGURE 48 JOHNSON & JOHNSON: COMPANY SNAPSHOT 316
FIGURE 49 STRYKER: COMPANY SNAPSHOT 321
FIGURE 50 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT 326
FIGURE 51 ABBOTT: COMPANY SNAPSHOT 331
FIGURE 52 ZIMMER BIOMET: COMPANY SNAPSHOT 334
FIGURE 53 B. BRAUN SE: COMPANY SNAPSHOT 337
FIGURE 54 GLOBUS MEDICAL: COMPANY SNAPSHOT 340
FIGURE 55 INTEGRA LIFESCIENCES CORPORATION: COMPANY SNAPSHOT 343
FIGURE 56 SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT 345
FIGURE 57 FUJIFILM CORPORATION: COMPANY SNAPSHOT 350
FIGURE 58 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT 354
FIGURE 59 INTUITIVE SURGICAL OPERATIONS, INC.: COMPANY SNAPSHOT 359
FIGURE 60 GE HEALTHCARE: COMPANY SNAPSHOT 365
MarketsandMarkets（マーケッツアンドマーケッツ）は世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。広範な市場を対象にした市場調査レポートを出版しています。
※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。
ライセンス別価格表
調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。
ライセンスタイプ1
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD4,950 | USD6,650 | USD8,150 | USD10,000 |
ライセンスタイプ2
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD7,150 | USD8,500 | USD9,650 | USD11,000 |
ライセンスタイプ3
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD8,150 | お問合せください | お問合せください | お問合せください |
ライセンスタイプ4
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD9,000 | USD10,500 | USD12,000 | USD13,500 |
ミニレポート ※定性調査にフォーカスした調査レポートです。詳細はお問合せください。
| シングルユーザ | コーポレート |
| USD 2,650 | USD 4,250 |
ご購入に関するご案内
価格・納期について
- 価格
- ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
- ライセンス
- シングルユーザライセンス
- 1名のみレポートファイルのご利用が可能です。
- マルチユーザライセンス
- 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
- コーポレートライセンス
- 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
- エンタープライズサイトライセンス
- 特別ライセンスです。適用範囲についてはお問合せください。
- シングルユーザライセンス
- 納品形態
- Eメール
- 納期
- 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）
ご注文方法
- レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。
その他
- 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。
株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。
最新調査レポート
- 自動車用アラミド繊維市場規模、シェア、動向、2030年までの世界予測 2025-12-15
- ポリヒドロキシアルカノエート (PHA) 市場規模、シェア、動向、2030年までの世界予測 2025-12-15
- 複合輸送市場規模、シェア、動向、2032年までの世界予測 2025-12-12
- 有機酸市場規模、シェア、動向、2030年までの世界予測 2025-12-11
- ハイブリッドボンディング市場規模、シェア、動向、2032年までの世界予測 2025-12-11